II. Symptoms
- See Pain Scale
- See Pain Assessment in Advanced Dementia Scale
- Assess patient's pain with a self rating Pain Scale
- Scale- No pain: 0
- Mild pain: 1-4
- Moderate pain: 5-6
- Severe pain: 7-10
 
III. Management: WHO Analgesic Ladder
- Step 1: Mild Pain (pain score of 1 to 4)- Adequate analgesia for 20-25% of cancer patients
- Acetaminophen
- Aspirin
- NSAIDs or COX2 Inhibitors
 
- Step 2: Moderate Pain (pain score of 5 to 6)- Acetaminophen with Codeine (Tylenol #3)
- Acetaminophen with Hydrocodone (Vicodin, Lorcet)
- Tramadol (Ultram)
 
- Step 3: Severe Pain (pain score of 7 to 10)- Morphine Sulfate
- Hydromorphone (Dilaudid)
- Transdermal Fentanyl
- Levorphanol
- Methadone- Cheap and effective (esp. neuropathic pain)
- Half-Life varies considerably (from 7 to 72 hours)
- Prescriptions typically limited to Palliative Care and pain management specialists
 
- Avoid Meperidine (Demerol)- Too short acting, lower efficacy
 
 
- Intractable Pain (Emergency Department)- Opioids as above (e.g. Morphine, Hydromorphone)
- Lidocaine (8 mg/ml)- Bolus: 1.5 mg/kg IV (up to 100 mg) delivered over 20-30 minutes
- Infusion: 0.5 to 2 mg/kg/hour (up to 100 mg/hour)
 
- Ketamine (Analgesic, low dose)- Dose: 0.1 to 0.2 mg/kg IV
- Effective in refractory non-Cancer Pain
- However, evidence for benefit in cancer-related pain is lacking
 
- Cannabinoids- Limited evidence to date of benefit in Cancer Pain
 
- Epidural or intrathecal medications- Opioids (Morphine, Hydromorphone)
- Ziconotide (Calcium Channel Blocker)
- Baclofen
- Bupivicaine
- Clonidine
 
- Other neuropathic pain agents
 
- Refractory Pain at the End of Life- Severe, refractory cancer Pain at the End of Life may require very high doses of Opioid Analgesics- These very high doses may result in apnea, and could shorten a patient's life
- When the goals of care are pain relief (not euthanasia), high doses are ethically supported
 
- Palliative Sedation- Consider in severe patient suffering despite maximal medical therapy
- Palliative Sedation (StatPearls)
 
 
- Severe, refractory cancer Pain at the End of Life may require very high doses of Opioid Analgesics
IV. Dosing: Routes of Administration
- Oral Route (90% of cancer cases, preferred route)- Peak effect in 1 hour after dosing
 
- Sublingual Route
- Subcutaneous (5% of cancer cases)- Programmed Subcutaneous pump is first choice option
- Peak effect 20-30 minutes after dosing
 
- Intravenous- Not typically used for Cancer Pain Management outside of hospital care
- Peak effect 10 minutes after dose
 
- Transdermal
- Rectal (5% of cancer cases)- Many oral preparations may be given rectally (e.g. MS Contin tablets)
 
- Avoid regular Intramuscular dosing (no indication)
V. Management: Somatic pain including bone metastases
- Pain Characteristics
- Medications: General- See Cancer Pain Narcotics
- COX2 Inhibitors (e.g. Vioxx or Celebrex)
- Nonsteroidal Antiinflammatory drugs (NSAIDs)
- Radioactive Strontium
 
- Medications: Bone Metastases- Bisphosphonates- Pamidronate (Aredia) 90 mg IV over 2-4 hours qMonth
 
- Calcitonin
- Corticosteroids- Prednisone 30 to 60 mg/day PO
- Dexamethasone 16 mg/day PO
- Methylprednisolone 120 mg/day PO
 
 
- Bisphosphonates
VI. Management: Neuropathic pain
- Type I: Chronic Lancinating Pain (Paroxysmal pain)- Characteristics- Sudden sharp, stabbing or "Zinger" pain
- Sudden knifelike pain
 
- Medications- Gabapentin (Neurontin) 100 mg PO tid
- Pregabalin (Lyrica)
- Carbamazepine (Tegretol) 200 mg PO bid
- Valproic Acid (Depakote) 10 mg/kg/day PO
- Clonazepam (Klonopin) 0.5 mg PO tid
- Lamotrigine (Lamictal) 50 mg PO qd
- Baclofen (Lioresal) 5 mg PO tid
 
 
- Characteristics
- Type II: Continuous Dysesthesias- Characteristics- Continuous burning
- Continuous electrical Sensations
 
- Medications- Tricyclic Antidepressants- Amitriptyline (Elavil) 30 to 100 mg PO qhs
- Doxepin (Sinequan) 50 to 75 mg PO qhs
- Imipramine (Tofranil) 50 to 75 mg PO qhs
 
- Systemic Anesthetics- Mexiletine (Mexitil) 200 mg PO q8 hours
- Tocainide (Tonocard) 400 mg PO q8 hours
 
- Other medications for refractory pain
 
- Tricyclic Antidepressants
 
- Characteristics
- Localized pain
VII. Management: Visceral Pain
- Characteristics- Squeezing
- Cramping
- Pressure-like pain
 
- Causes- Hepatic metastases
- Biliary obstruction
- Bowel Obstruction
- Pancreatitis
 
- Medications- General analgesia
- Capsule swelling (e.g. hepatic)
- Bowel Obstruction
- Biliary Colic
 
VIII. References
- Glauser and Money (2019) Crit Dec Emerg Med 23(8): 3-10
- Abrahm (1999) Ann Intern Med 131:37-46 [PubMed]
- Cherny (2000) CA Cancer J Clin 50(2):70-116 [PubMed]
- Groninger (2014) Am Fam Physician 90(1): 26-32 [PubMed]
- Levy (1996) N Engl J Med 335:1124-32 [PubMed]
- Miller (2001) Am Fam Physician 64(7):1227-34 [PubMed]
